Peltz Stuart Walter's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Feb 2, 2023
- Accession no.
- 0001415889-23-001803
- Filed
- Feb 2, 2023
- Trade date
- Jan 31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $119.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Peltz Stuart WalterCIK 0001578962 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Common Stock | SSaleDisposed | −2,320 | $45.63 | −$105,861.6 | 166,962 | Direct | |
| Jan 31, 2023 | Common Stock | SSaleDisposed | −301 | $45.63 | −$13,734.63 | 54,903 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.